Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 637523, 5 pages
http://dx.doi.org/10.1155/2014/637523
Research Article

HS1,2 Ig Enhancer Alleles Association to AIDS Progression in a Pediatric Cohort Infected with a Monophyletic HIV-Strain

1Department of Biology, University of Rome “Tor Vergata,” 00133 Rome, Italy
2Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada V5Z 1L3
3University Department of Pediatrics, DPUO, Unit of Immune and Infectious Diseases, Children’s Hospital “Bambino Gesù,” 00165 Rome, Italy
4Istituto Mario Negri Sud, 66030 Chieti, Italy
5International Training Unit, Children’s Hospital “Bambino Gesù,” 00165 Rome, Italy
6San Pietro Fatebenefratelli Hospital, 00189 Rome, Italy
7Department of Biomedicine and Prevention, University of Rome “Tor Vergata,” 00133 Rome, Italy
8ProxAgen Ltd., 1505 Sofia, Bulgaria

Received 28 February 2014; Revised 28 April 2014; Accepted 28 April 2014; Published 20 May 2014

Academic Editor: Esteban Martinez

Copyright © 2014 Carla Montesano et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Carrington, G. W. Nelson, M. P. Martin et al., “HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage,” Science, vol. 283, no. 5408, pp. 1748–1752, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. N. Casartelli, G. Di Matteo, C. Argentini et al., “Structural defects and variations in the HIV-1 nef gene from rapid, slow and non-progressor children,” AIDS, vol. 17, no. 9, pp. 1291–1301, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. B. Rodriguez, A. K. Sethi, V. K. Cheruvu et al., “Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection,” The Journal of the American Medical Association, vol. 296, no. 12, pp. 1498–1506, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. A. De Milito, “B lymphocyte dysfunctions in HIV infection,” Current HIV Research, vol. 2, no. 1, pp. 11–21, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. A. M. Levine, “Monoclonal gammopathy associated with HIV infection,” Clinical Infectious Diseases, vol. 43, no. 9, pp. 1206–1208, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Moir and A. S. Fauci, “B cells in HIV infection and disease,” Nature Reviews Immunology, vol. 9, no. 4, pp. 235–245, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Pensieroso, A. Cagigi, P. Palma et al., “Timing of HAART defines the integrity of memory B cells and the longevity of humoral responses in HIV-1 vertically-infected children,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 19, pp. 7939–7944, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. E. Pinaud, A. A. Khamlichi, C. Le Morvan et al., “Localization of the 3′ IgH locus elements that effect long-distance regulation of class switch recombination,” Immunity, vol. 15, no. 2, pp. 187–199, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Pinaud, M. Marquet, R. Fiancette et al., “The IgH locus 3′ regulatory region: pulling the strings from behind,” Advances in Immunology, vol. 110, pp. 27–70, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Hu, Q. Pan, E. Pardali et al., “Regulation of germline promoters by the two human Ig heavy chain 3′ alpha enhancers,” Journal of Immunology, vol. 164, no. 12, pp. 6380–6386, 2000. View at Google Scholar · View at Scopus
  11. D. Frezza, V. Giambra, C. Mattioli et al., “Allelic frequencies of 3′ Ig heavy chain locus enhancer HS1,2-A associated with Ig levels in patients with schizophrenia,” International Journal of Immunopathology and Pharmacology, vol. 22, no. 1, pp. 115–123, 2009. View at Google Scholar · View at Scopus
  12. V. Giambra, C. Martínez-Labarga, M. Giufre' et al., “Immunoglobulin enhancer HS1,2 polymorphism: a new powerful anthropogenetic marker,” Annals of Human Genetics, vol. 70, no. 6, pp. 946–950, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Frezza, V. Giambra, R. Cianci et al., “Increased frequency of the immunoglobulin enhancer HS1,2 allele 2 in coeliac disease,” Scandinavian Journal of Gastroenterology, vol. 39, no. 11, pp. 1083–1087, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Cianci, V. Giambra, C. Mattioli et al., “Increased frequency of Ig heavy-chain HS1,2-A enhancer *2 allele in dermatitis herpetiformis, plaque psoriasis, and psoriatic arthritis,” Journal of Investigative Dermatology, vol. 128, no. 8, pp. 1920–1924, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. V. Giambra, R. Cianci, S. Lolli et al., “Allele *1 of HS1.2 enhancer associates with selective IgA deficiency and IgM concentration,” Journal of Immunology, vol. 183, no. 12, pp. 8280–8285, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Aupetit, M. Drouet, E. Pinaud et al., “Alleles of the alpha1 immunoglobulin gene 3′ enhancer control evolution of IgA nephropathy toward renal failure,” Kidney International, vol. 58, no. 3, pp. 966–971, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. T. de Oliveira, O. G. Pybus, A. Rambaut et al., “Molecular epidemiology: HIV-1 and HCV sequences from Libyan outbreak,” Nature, vol. 444, no. 7121, pp. 836–837, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. Centers for Disease Control Prevention, “Revised classification system for human immunodeficiency virus infection in children less than 13 years of age,” Morbidity and Mortality Weekly Report, vol. 43, pp. 1–19, 1994. View at Google Scholar
  19. A. Petrucci, M. Dorrucci, M. Alliegro et al., “How many HIV-infected individuals may be defined as long-term non-progressors? A report from the Italian Seroconversion Study,” Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, vol. 14, no. 3, pp. 243–248, 1997. View at Google Scholar
  20. S. Yerly, R. Quadri, F. Negro et al., “Nosocomial outbreak of multiple bloodborne viral infections,” Journal of Infectious Diseases, vol. 184, no. 3, pp. 369–372, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Grifoni, C. Montesano, P. Palma, A. Salerno, V. Colizzi, and M. Amicosante, “Role of HLA-B alfa-3 domain amino acid position 194 in HIV disease progression,” Molecular Immunology, vol. 53, no. 4, pp. 410–413, 2013. View at Publisher · View at Google Scholar
  22. C. Montesano, C. T. Bonanno, A. Grifoni et al., “Impact of human leukocyte antigen polymorphisms in human immunodeficiency virus progression in a paediatric cohort infected with a mono-phyletic human immunodeficiency virus-1 strain,” Journal of AIDS and Clinical Research, vol. 5, article 282, pp. 2155–6113, 2014. View at Publisher · View at Google Scholar
  23. V. Giambra, A. Fruscalzo, M. Giufre' et al., “Evolution of human IgH3′EC duplicated structures: both enhancers HS1,2 are polymorphic with variation of transcription factor's consensus sites,” Gene, vol. 346, pp. 105–114, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. G. Kaur and N. Mehra, “Genetic determinants of HIV-1 infection and progression to AIDS: immune response genes,” Tissue Antigens, vol. 74, no. 5, pp. 373–385, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. E. A. Trachtenberg and H. A. Erlich, “A review of the role of the human leukocyte antigen (HLA) system as a host immunogenetic factor influencing HIV transmission and course of infection with progression to AIDS,” in HIV Molecular Immunology Database, B. T. Korber, C. Brander, B. F. Haynes et al., Eds., pp. 1–60, 2001. View at Google Scholar
  26. C. G. Anastassopoulou and L. G. Kostrikis, “The impact of human allelic variation on HIV-1 disease,” Current HIV Research, vol. 1, no. 2, pp. 185–203, 2003. View at Google Scholar · View at Scopus
  27. A. J. McMichael and S. L. Rowland-Jones, “Cellular immune responses to HIV,” Nature, vol. 410, no. 6831, pp. 980–987, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. D. Frezza, B. Tolusso, V. Giambra et al., “Polymorphisms of the IgH enhancer HS1, 2 and risk of systemic lupus erythematosus,” Annals of the Rheumatic Diseases, vol. 71, pp. 1309–1315, 2012. View at Publisher · View at Google Scholar
  29. L. Yu, A. J. Mohamed, O. E. Simonson et al., “Proteasome-dependent autoregulation of bruton tyrosine kinase (Btk) promoter via NF-kB,” Blood, vol. 111, no. 9, pp. 4617–4626, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. B. Rodriguez, H. Valdez, W. Freimuth, T. Butler, R. Asaad, and M. M. Lederman, “Plasma levels of B-lymphocyte stimulator increase with HIV disease progression,” AIDS, vol. 17, no. 13, pp. 1983–1985, 2003. View at Publisher · View at Google Scholar · View at Scopus